Description
CAPRELSA 300MG (1 BT)
First action · last action
2012-08-14 · 2012-08-14
Transactions
1
First transaction's obligation
$7,335
Base + all options value (sum of deltas)
$7,335
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797P12A0007
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-08-14+$7,335= $7,335
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-08-14 | +$7,335 | $7,335 | CAPRELSA 300MG (1 BT) |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FBWCB39K5929)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA24117F0409 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $62,720 | FY2017 |
| VA24916J2992 | 596-LEXINGTON(00596) · 6505 · DRUGS AND BIOLOGICALS | $9,360 | FY2016 |
| VA24816F1925 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $7,567 | FY2016 |
| VA24916J2473 | 626-NASHVILLE (00626) · 6505 · DRUGS AND BIOLOGICALS | $10,442 | FY2016 |
| VA24916J2234 | 596-LEXINGTON(00596) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA24816F1550 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $7,567 | FY2016 |
Other recipients under 6505 from 520-BILOXI (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613F0132 | LUNDBECK LLC | 520-BILOXI | $4,351 | FY2013 |
| VA25613F0083 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 520-BILOXI | $6,114 | FY2013 |
| VA25612F2354 | LUNDBECK LLC | 520-BILOXI | $4,351 | FY2012 |
| VA25612F2324 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 520-BILOXI | $6,114 | FY2012 |
| VA25612F2106 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 520-BILOXI | $6,166 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25612F2146_3600_VA797P12A0007_3600 · retrieved 2026-09-26.